Pharmacodynamic of Ceftaroline and Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
This study will further analyze the use of ceftaroline for CABP and compare its potential to
eradicate bacterial pathogens to standard fluoroquinolone therapy. The enhanced spectrum of
ceftaroline compared to levofloxacin may be further highlighted from this investigation.